AzTrials
AzTrials

Umbilical Cord MilkingNCT05951348

Comparing Delayed Cord Clamping and Umbilical Cord Milking During Elective Cesarean Section for the Neonatal Outcome

A study testing Delayed cord clamping for 30 seconds in people with Umbilical Cord Milking, run by Alexandria University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

the study is conducted on the different actions on umbilical cord clamping including immediate cord clamping (ICC) , delayed cord clamping (DCC) for 30 seconds and umbilical cord milking (UCM) for 10-15 seconds in females that are delivered by elective cesarean section , to assess the neonatal outcomes including… Read more about this study

Who is it for?
Ages 20 to 40 years, women only
Conditions the study is for
Umbilical Cord Milking
What is being tested?
Delayed cord clamping for 30 seconds
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
162 participants
Where
1 siteEgypt
Study dates
11 Nov 2021to 20 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • mother's age (20-40) years.
  • pregnancy with a healthy singleton
  • gestational age of 38-41 0/7 weeks
  • uncomplicated pregnancy

Who cannot join

  • Any medical or obstetrical complications like hypertension, pre-eclampsia, diabetes any special habits like smoking, and substance abuse
  • Rh-negative mothers. The fetal exclusion criteria
  • fetus with evidence of intrauterine growth restriction
  • infant with serious congenital anomalies.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Tamer Ahmed Hosny

    Alexandria

Other trials in Egypt

About this study

the study is conducted on the different actions on umbilical cord clamping including immediate cord clamping (ICC) , delayed cord clamping (DCC) for 30 seconds and umbilical cord milking (UCM) for 10-15 seconds in females that are delivered by elective cesarean section , to assess the neonatal outcomes including Hemoglobin and Hematocrit levels after birth in the newborn and the bilirubin level after 72 hrs

Read the detailed description

the benefit of umbilical cord milking for 10-15 seconds maneuver in cesarean section, that short time can improve the hemoglobin level and prevent anemia in the newborn with improvement of the iron stores for months in infancy without affection on the bilirubin level and the need for phototherapy. This is significant because of the rising rate of cesarean section all over the world make more children are liable for anemia, and by this simple technique it can be prevented.

Being tested
Delayed cord clamping for 30 seconds
Keywords
cesarean section, umbilical cord milking, hemoglobin

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Delayed cord clamping for 30 secondsProcedure or surgery

    Also called Umbilical cord milking

    waiting for 30 seconds after delivery of the fetus or milking of the cord in the direction of the fetus 10 times in time frame 10-15 seconds

Study groups in NCT05951348
Study groupRoleWhat they receive
Immediate cord clampingNo interventionthis arm where the patient didn't receive any special maneuver and immediate cord clamping after delivery of the fetus is done
Delayed cord clampingExperimentalthis arm where the patient receive a delay in cord clamping for 30 seconds after delivery of the fetus
Receives: Procedure: Delayed cord clamping for 30 seconds
Umbilical cord milkingExperimentalthis arm where the patient receive stripping of the umbilical cord in the direction of the fetus 10 times in a time frame 10-15 seconds after delivery of the fetus
Receives: Procedure: Delayed cord clamping for 30 seconds

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. hemoglobin level

    a blood sample is taken from the umbilical cord of the neonate

    Measured: immediately after the intervention

Secondary outcomes (1)
  1. bilirubin level

    trans-cutaneous measurement of the bilirubin level

    Measured: 72 hours after delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2023
  2. Study start11 Nov 2021
  3. Primary completion20 Jun 2022
  4. Study completion20 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
162 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05951348
Sponsor's protocol ID
0106748
Status last verified
May 2023
First submitted
6 Jul 2023
Last updated
21 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Delayed cord clamping for 30 seconds in people with Umbilical Cord Milking, run by Alexandria University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

hemoglobin level (time frame: immediately after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in